Henry Schein Shares Rise on Fluoride Speculation

Stocks of dental care suppliers surged following speculation that Robert F. Kennedy Jr., nominated by President-elect Donald Trump for Health and Human Services secretary, may push to eliminate fluoride from U.S. drinking water. Shares of Henry Schein rose over 7%, while Dentsply Sirona and Envista also experienced gains, as investors anticipate increased demand for dental services due to potential spikes in tooth decay. Kennedy's anti-fluoride stance has raised concerns among dental experts, who emphasize the effectiveness of fluoride in reducing cavities, despite claims of health risks associated with its use. The reaction in the market reflects fears of regulatory changes under a second Trump administration, which could take years to implement. Analysts note that while the short-term market response is notable, the actual impact of such policies on public health remains uncertain, highlighting the divide between investor optimism and professional skepticism regarding fluoride's safety. Overall, the situation illustrates a complex interplay between health policy and market dynamics in the dental care sector.